查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540966

2024-2032 年按疫苗类型、技术、给药途径、配销通路和地区分類的兽用疫苗市场报告

Veterinary Vaccines Market Report by Vaccine Type, Technology, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球兽用疫苗市场规模达136亿美元。

兽用疫苗代表生物製备的免疫，透过肠胃外和口服途径对家畜或野生物种施用，以刺激保护性免疫反应，而不引起疾病本身。它们涉及灭活疫苗、减毒活疫苗和重组疫苗等一些常见药物。这些接种有助于减少动物的痛苦，提高免疫效率，并防止发生和传播各种传染性人畜共通传染病的风险。除此之外，兽用疫苗具有成本效益、可靠，并能提供长期预防，因此也被用来增加全球牲畜的产量。

兽用疫苗市场趋势：

全球兽用疫苗市场的主要动力是对有效免疫产品的需求不断增长以及各种传染性流行病盛行率的上升。这可以进一步归因于全球范围内伴侣动物和家畜动物的驯化以及对宠物健康的日益关注。与此一致的是，政府为改善新型兽用疫苗生产程序而在製药业进行的大量投资是另一个成长诱导因素。此外，脱氧核糖核酸（DNA）和核糖核酸（RNA）疫苗的推出提高了产品稳定性、功效和给药途径，也有助于市场成长。除此之外，肌内无针疫苗注射的创新以及消费者对其有益特性（例如增强的安全性和减少疼痛）的认识不断提高，正在推动市场成长。此外，对兽用疫苗的需求不断增加，以防止来自畜牧产品（包括牛奶、肉类、皮革、鸡蛋和羊毛）的携带疾病的微生物传播，这正在积极刺激市场成长。其他因素，例如医疗保健基础设施的显着改善、持续的研发 (R&D) 活动以及主要参与者之间为提高兽用疫苗效率而进行的策略合作，正在为市场创造积极的前景。

本报告回答的关键问题：

  • 迄今为止，全球兽用疫苗市场表现如何，未来几年将如何表现？
  • COVID-19 对全球兽用疫苗市场有何影响？
  • 主要区域市场有哪些？
  • 根据疫苗类型，市场的细分情况如何？
  • 基于技术的市场区隔是什么？
  • 根据给药途径，市场的分化为何？
  • 基于配销通路的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球兽用疫苗市场结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球兽用疫苗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依疫苗类型

  • 牲畜疫苗
    • 市场趋势
    • 关键环节
      • 牛疫苗
      • 家禽疫苗
      • 猪疫苗
      • 其他的
    • 市场预测
  • 伴侣动物疫苗
    • 市场趋势
    • 关键环节
      • 犬疫苗
      • 猫疫苗
      • 马疫苗
    • 市场预测

第 7 章：市场区隔：依技术

  • 减毒活疫苗
    • 市场趋势
    • 市场预测
  • 灭活疫苗
    • 市场趋势
    • 市场预测
  • 类毒素疫苗
    • 市场趋势
    • 市场预测
  • 重组疫苗
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依管理途径

  • 皮下
    • 市场趋势
    • 市场预测
  • 肌肉注射
    • 市场趋势
    • 市场预测
  • 鼻内
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按配销通路

  • 兽医院
    • 市场趋势
    • 市场预测
  • 兽医诊所
    • 市场趋势
    • 市场预测
  • 药局和药局
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Elanco Animal Health Incorporated
    • Hester Biosciences Limited
    • HIPRA
    • Indian Immunologicals Limited
    • Merck & Co. Inc.
    • Neogen Corporation
    • Phibro Animal Health Corporation
    • Virbac SA
    • Zoetis Inc.
Product Code: SR112024A6493

The global veterinary vaccines market size reached US$ 13.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.0 Billion by 2032, exhibiting a growth rate (CAGR) of 8.12% during 2024-2032.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases. Apart from this, veterinary vaccines are cost-effective, reliable, and offer long-term prevention, due to which they are also used to increase the production of livestock across the globe.

Veterinary Vaccines Market Trends:

The global veterinary vaccines market is majorly driven by the increasing demand for effective immunization products and the rising prevalence of various infectious epizootic disorders. This can be further attributed to the domestication of both companion and livestock animals across the globe and the enhanced focus on pet health. In line with this, extensive investments by governments in the pharmaceutical sector to improve novel veterinary vaccine manufacturing procedures are acting as another growth-inducing factor. Additionally, the introduction of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) vaccines with improved product stability, efficacy, and route administration approach is contributing to the market growth. Besides this, the innovation of intramuscular needle-free vaccine injections and growing awareness amongst consumers regarding their beneficial properties, such as enhanced safety and less pain, is propelling the market growth. Moreover, the fueling need for veterinary vaccines to prevent the transmission of disease-carrying microbes from livestock-based products, including milk, meat, leather, eggs, and wool, is positively stimulating the market growth. Other factors, such as significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and strategic collaborations amongst key players to enhance the efficiency of veterinary vaccines, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary vaccines market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on vaccine type, technology, route of administration and distribution channel.

Breakup by Vaccine Type:

Livestock Vaccines

Bovine Vaccines

Poultry Vaccines

Porcine Vaccines

Others

Companion Animal Vaccines

Canine Vaccines

Feline Vaccines

Equine Vaccines

Breakup by Technology:

Attenuated Live Vaccines

Inactivated Vaccines

Toxoid Vaccines

Recombinant Vaccines

Others

Breakup by Route of Administration:

Subcutaneous

Intramuscular

Intranasal

Breakup by Distribution Channel:

Veterinary Hospitals

Veterinary Clinics

Pharmacies and Drug Stores

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, Indian Immunologicals Limited, Merck & Co. Inc., Neogen Corporation, Phibro Animal Health Corporation, Virbac SA and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global veterinary vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global veterinary vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Livestock Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Bovine Vaccines
      • 6.1.2.2 Poultry Vaccines
      • 6.1.2.3 Porcine Vaccines
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Companion Animal Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Canine Vaccines
      • 6.2.2.2 Feline Vaccines
      • 6.2.2.3 Equine Vaccines
    • 6.2.3 Market Forecast

7 Market Breakup by Technology

  • 7.1 Attenuated Live Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Inactivated Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Toxoid Vaccines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Recombinant Vaccines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Subcutaneous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Intranasal
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Veterinary Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmacies and Drug Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Boehringer Ingelheim International GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Ceva Sante Animale
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Elanco Animal Health Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 Hester Biosciences Limited
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 HIPRA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Indian Immunologicals Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck & Co. Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Neogen Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phibro Animal Health Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Virbac SA
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Zoetis Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials

List of Figures

  • Figure 1: Global: Veterinary Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2023
  • Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
  • Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
  • Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
  • Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Veterinary Vaccines Market: Competitive Structure
  • Table 8: Global: Veterinary Vaccines Market: Key Players